Decreased NADH dehydrogenase and ubiquinol-cytochrome c oxidoreductase in peripheral arterial disease

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 280, Issue 2 49-2, 2001, Pages

  Brass, Eric P ^a   Hiatt, William R ^b   Gardner, Andrew W ^c   Hoppel, Charles L ^d  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Exercise; Mitochondria

Indexed keywords

CITRATE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; UBIQUINOL CYTOCHROME C REDUCTASE;

ADULT; AGED; ARTERY DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTRON TRANSPORT; ENZYME ACTIVITY; EXERCISE; FEMALE; GASTROCNEMIUS MUSCLE; HUMAN; HUMAN TISSUE; MALE; MITOCHONDRION; MUSCLE BIOPSY; MUSCLE METABOLISM; PRIORITY JOURNAL; SKELETAL MUSCLE;

EID: 0035012131     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2001.280.2.h603     Document Type: Article

References (41)

1. Ames BN, Shigenaga MK, and Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 90: 7915-7922, 1993.
2. Bakker HD, Scholtz HR, Jeneson JA, Busch HF, Abeling NG, and van Gennip AH. Vitamin-responsive complex I deficiency in a myopathic patient with increased activity of the terminal respiratory chain and lactic acidosis. J Inherit Metab Dis 17: 196-204, 1994.
3. Bauer TA, Regensteiner JG, Brass EP, and Hiatt WR. Oxygen uptake kinetics during exercise are slowed in patients with peripheral arterial disease. J Appl Physiol 87: 809-816, 1999.
4. Belch JJF, Chopra M, Hutchinson S, Lorimer R, Sturrock RD, Forbes CD, and Smith WE. Free radical pathology in chronic arterial disease. Free Radic Biol Med 6: 375-378, 1989.
5. Bhat HK, Hiatt WR, Hoppel CL, and Brass EP. Skeletal muscle mitochondrial DNA injury in patients with unilateral arterial disease. Circulation 99: 807-812, 1999.
6. Brass EP. Skeletal muscle metabolism as a target for drug therapy in peripheral arterial disease. Vasc Med 1: 55-59, 1996.
7. Brass EP and Hiatt WR. Acquired skeletal muscle metabolic myopathy in atherosclerotic peripheral arterial disease. Vasc Med 5: 55-59, 2000.
8. Bylund AC, Hammersten J, Holm J, and Schersten T. Enzyme activities in skeletal muscle from patients with peripheral arterial insufficiency. Eur J Clin Invest 6: 425-429, 1976.
9. Corral-Debrinski M, Stepian G, Shoffner JM, Lott MT, Keuter K, and Wallace DC. Hypoxemia is associated with mitochondrial DNA damage and gene induction. JAMA 266: 1812-1816, 1991.
10. Gardner AW, Skinner JS, Cantwell BW, and Smith LK. Progressive versus single-stage treadmill tests for evaluation of claudication. Med Sci Sports Exerc 23: 402-408, 1991.
11. Gardner AW, Skinner JS, Cantwell BW, and Smith LK. Prediction of claudication pain from clinical measurements obtained at rest. Med Sci Sports Exerc 24: 163-170, 1992.
12. Grigorieff N. Structure of the respiratory NADH:ubiquinone oxidoreductase (complex I). Curr Opin Struct Biol 9: 476-483, 1999
13. Haas RH, Nasorian F, Nakano K, Ward D, Pay M, Hill R, and Shults CW. Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease. Ann Neurol 37: 714-722, 1995.
14. Haller RG, Lewis SF, Esterbrook RW, DiMauro S, Servidei S, and Foster DW. Exercise intolerance, lactic acidosis, and abnormal cardiopulmonary regulation in exercise associated with adult skeletal muscle cytochrome c oxidase deficiency. J Clin Invest 84: 155-161, 1989.
15. Hiatt WR, Huag S, and Hamman RF. Effect of diagnostic criteria on the prevalence of peripheral arterial disease: the San Luis Valley diabetes study. Circulation 99: 1472-1479, 1995.
16. Hiatt WR, Nawaz D, and Brass EP. Carnitine metabolism during exercise in patients with peripheral vascular disease. J Appl Physiol 62: 2383-2387, 1987.
17. Hiatt WR, Regensteiner JG, Wolfel EE, Carry MR, and Brass EP. Effect of exercise training on skeletal muscle histology and metabolism in peripheral arterial disease. J Appl Physiol 81: 780-788, 1996.
18. Hiatt WR, Wolfel EE, Regensteiner JG, and Brass EP. Skeletal muscle carnitine metabolism in patients with unilateral peripheral arterial disease. J Appl Physiol 73: 346-353, 1992.
19. Hickman P, Harrison DK, Hill A, McLaren M, Tamei H, McCollum PT, and Belch JJF. Exercise in patients with intermittent claudication results in the generation of oxygen-derived free radicals and endothelial damage. Adv Exp Med Biol 361: 565-570, 1994.
20. Holloszy JO and Coyle E. Adaptation of skeletal muscle to endurance exercise and their metabolic consequences. J Appl Physiol 56: 8831-8838, 1984.
21. Hoppel CL, Kerr DS, Dahms B, and Roessmann V. Deficiency of the reduced nicotinamide adenine dinucleotide dehydrogenase component of complex I of mitochondrial electron transport: fatal infantile lactic acidosis and hypermetabolism with skeletal-cardiac myopathy and encephalopathy. J Clin Invest 80: 71-77, 1987.
22. 31P magnetic resonance spectroscopy of abnormal mitochondrial oxidation in skeletal muscle during recovery from exercise. NMR Biomed 6: 302-310, 1993.
23. Krahenbuhl S, Chang M, Brass EP, and Hoppel CL. Decreased activities of ubiquinol:ferricytochrome c oxidoreductase (complex III) and ferrocytochrome c:oxygen oxidoreductase (complex IV) in liver mitochondria from rats with hydroxycobalamin [c-lactam]-induced methylmalonic aciduria. J Biol Chem 266: 20998-21003, 1991.
24. Krahenbuhl S, Talso C, Wiesmann U, and Hoppel CL. Development and evaluation of a spectrophotometric assay for complex III in isolated mitochondria, tissues and fibroblasts from rats and humans. Clin Chem Acta 230: 177-187, 1994.
25. Lesnefsky EJ, Tandler B, Ye J, Slabe TJ, Turkaly J, and Hoppel CL. Myocardial ischemia decreases oxidative phosphorylation through cytochrome oxidase in subsarcolemmal mitochondria. Am J Physiol Heart Circ Physiol 273: H1544-H1554, 1997.
26. Okuda M, Lee H-C, Chance B, and Kumar C. Reactive oxygen species production in the isolated perfused rat liver: effect of respiratory inhibitors. J Clin Biochem Nutr 15: 91-104, 1993.
27. Pernow B and Zelterquist S. Metabolic evaluation of the leg blood flow in claudication patients with arterial obstruction at different levels. Scand J Clin Lab Invest 21: 277-287, 1968.
28. Reilly M, Delanty N, Lawson JA, and FitzGerald GA. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 94: 19-25, 1996.
29. Rossingnol R, Malgat M, Mazat J-P, and Letellier T. Threshold effect and tissue specificity: implication for mitochondrial cytopathies. J Biol Chem 274: 33426-33432, 1999.
30. Rouslin W. Mitochondrial complexes I, II, III, IV and V in myocardial ischemia and autolysis. Am J Physiol Heart Circ Physiol 244: H743-H748, 1983.
31. Rouslin W and Ranganathan S. Impaired function of mitochondrial electron transfer complex I in canine myocardial ischemia: loss of flavin mononucleotide. J Mol Cell Cardiol 15: 537-542, 1983.
32. 10 in mitochondrial respiratory chain and oxygen-derived free radical generation in cardiac cells. Mol Aspects Med 18 Suppl: S41-S50, 1997.
33. Schapira AH, Cooper JM, Dexter D, Clark JB, Jenner P, and Marsden CD. Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 54: 823-827, 1990.
34. Srere PA. Citrate synthase. Methods Enzymol 13: 3-11, 1969.
35. Taylor RW, Birch-Machin MA, Bartlett K, Lowerson SA, and Turnbull DM. The control of mitochondrial oxidation by complex III in rat muscle and liver mitochondria. J Biol Chem 269: 3523-3528, 1994.
36. Van Jaarsveld H, Potgieter GM, and Lochner A. Enzymatic and structural modifications of mitochondrial NADH-ubiquinone reductase with autolysis as an experimental model. Enzyme (Basel) 39: 151-160, 1988.
37. Veitch K, Hombroeckx A, Caucheteux D, Pouleur H, and Hue L. Global ischemia induces a biphasic response of the mitochondrial respiratory chain. Anoxic pre-perfusion protects against ischemic damage. Biochem J 281: 709-715, 1992.
38. Wang H, Hiatt WR, Barstow TJ, and Brass EP. Relationship between muscle mitochondrial enzyme activity and oxidative capacity in man: alterations with disease. Eur J Appl Physiol 80: 22-27, 1999.
39. Wharton DC and Tzagoloff A. Cytochrome oxidase. Methods Enzymol 10: 245-250, 1967.
40. Zhang L, Yu L, and Yu CA. Generation of Superoxide anion by succinate-cytochrome c reductase from bovine heart mitochondria. J Biol Chem 51: 33972-33976, 1998.
41. Zhang Y, Marcillat O, Giulivi C, Ernster L, and Davies KJA. The oxidative inactivation of mitochondrial electron transport chain components and ATPase. J Biol Chem 265: 16330-16336, 1990.